Taking clinical trials to the patient
Putting patients at the center of trials in Japan using new tools and approaches
Close log in window
Remote patient participation and trial monitoring can avoid the high risk of hospital visits
With the whole of pharma in various states of ‘hybridisation’, how can MSLs be supported to deliver enhanced personal service across phy...
The serendipitous nature of face-to-face peer interactions is hard to recreate in digital contexts but a focus on small, two-way interaction...
In our Q&A with Dave Fredrickson, we explore the efforts to continue innovating and bringing better care to cancer patients during and b...
